Purdue's Ch. 11 Plan Hangs On Sackler Liability Question
The viability of Purdue Pharma's much anticipated Chapter 11 plan hangs on whether creditors are willing to release the Sackler family from what could be heaps of liability in exchange for...To view the full article, register now.
Already a subscriber? Click here to view full article